Ignite Creation Date:
2025-12-24 @ 2:17 PM
Ignite Modification Date:
2025-12-29 @ 1:11 PM
Study NCT ID:
NCT01297595
Status:
COMPLETED
Last Update Posted:
2012-02-16
First Post:
2011-02-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-03
Start Date Type:
None
Primary Completion Date:
2011-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-04
Completion Date Type:
ACTUAL
First Submit Date:
2011-02-15
First Submit QC Date:
None
Study First Post Date:
2011-02-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-01-05
Results First Submit QC Date:
None
Results First Post Date:
2012-02-08
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-02-15
Last Update Post Date:
2012-02-16
Last Update Post Date Type:
ESTIMATED